Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARQULE INC | 65,000 | reported | 13 May 2010 | tx 6+65,000 |
| Generate Biomedicines, Inc. | 29,561 | reported | 26 Feb 2026 | tx 1+29,561 |
| Evelo Biosciences, Inc. | 15,690 | reported | 17 Jun 2020 | tx 3+62,760 |
| Syros Pharmaceuticals, Inc. | 4,000 | reported | 02 Dec 2024 | tx 53+3,446,926−836,903 |
| SEATTLE GENETICS INC /WA | 0 | reported | 14 Dec 2023 | tx 37+161,684−161,684 |
| MILLENNIUM PHARMACEUTICALS INC | 0 | reported | 14 May 2008 | tx 42+280,984−821,173 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Feb 2026 | GRANT_AWARD | Generate Biomedicines, Inc. | 29,561 | 0.00 USD | deriv |
| 02 Dec 2024 | SALE | Syros Pharmaceuticals, Inc. | 37,070 | 0.27 USD | |
| 25 Nov 2024 | SALE | Syros Pharmaceuticals, Inc. | 134,713 | 0.27 USD | |
| 31 Oct 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 40,125 | — | |
| 31 Oct 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 40,125 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 4,000 | 0.00 USD | |
| 05 Jun 2024 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 6,000 | 0.00 USD | deriv |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 6,000 | — | |
| 01 Apr 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 14,052 | 5.12 USD | |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 39,566 | — | |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 39,566 | 0.00 USD | deriv |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 6,000 | 0.00 USD | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 62,753 | 229.00 USD | |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 8,750 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 9,260 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 9,260 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 9,260 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 2,044 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 7,038 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 3,171 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 3,462 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 3,676 | — | deriv |
| 14 Dec 2023 | OTHER | SEATTLE GENETICS INC /WA | 9,260 | — | deriv |
| 01 Dec 2023 | OTHER | Syros Pharmaceuticals, Inc. | 7,500 | — | deriv |
| 01 Dec 2023 | OTHER | Syros Pharmaceuticals, Inc. | 17,499 | — | deriv |